GeneDx Corp.
WGS | NASDAQ
$97.83
-$3.27 (-3.23%)
At close: Sep 21, 2026, 4:00 PM ET
$94.97
-$2.86 (-2.92%)
Pre-market:
Sep 22, 2026, 8:28 AM ET
Market Data
Market Cap $2.92B
Enterprise Value $2.95B
Beta 2.01
Average Volume 1.15M
Shares Outstanding (Diluted) 29.71M
Shares Change YoY -0.15%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US81663L2007
Price Performance
Price Change 1M 13.4%
Price Change 3M 68.4%
Price Change 6M 46.1%
Price Change YTD -26.1%
Price Change 1Y -24.6%
Price Change 3Y 2625.1%
Price Change 5Y -63.7%
1M CAGR (ann.) 26.9%
1Y CAGR (ann.) -25.1%
5Y CAGR (ann.) -19.5%
All-Time CAGR -18.4%
Valuation
PE Ratio -27.02
Forward PE 92.68
PEG Ratio -0.01
Forward PEG -0.03
PS Ratio 6.42
Forward PS 4.90
PB Ratio 11.95
P/FCF Ratio -38.49
P/Adj. FCF Ratio -26.17
P/OCF Ratio -59.65
EV/Sales 6.50
EV/EBIT -29.41
EV/EBITDA -35.35
EV/FCF -38.95
Earnings Yield -3.7%
FCF Yield -2.6%
Adj. FCF Yield -3.8%
Financial Health
Net Cash $30M
Total Debt $167.4M
Cash & Short-Term Investments $132.55M
Total Assets $481.49M
Current Ratio 3.30
Quick Ratio 3.06
Debt / Equity Ratio 0.69
Debt / EBITDA -2.00
Debt / FCF -2.21
OCF / Debt -0.29
Interest Coverage -20.31
Altman Z-Score 3.83
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 68.2%
Operating Profit Margin -12.6%
EBITDA Margin -16.8%
Net Profit Margin -23.4%
FCF Margin -16.7%
Adj. FCF Margin -24.5%
SBC / Revenue 7.9%
SBC Impact (per share) -47.1%
Returns
Return on Assets -22.1%
Return on Equity -38.7%
Return on Invested Capital -14.7%
Return on Capital Employed -14.9%
Return on Tangible Assets -31.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 24.3%
Revenue CAGR 5Y 16.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 16.5%
EPS CAGR 5Y 51.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y 17.8%
FCF CAGR 5Y 48.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 61.0%
Revenue Growth Next 3Y 23.9%
Earnings Date Oct 26, 2026
EPS Estimate (next Q) $0.07
EPS Growth Est (next Q) -85.7%
Revenue Est (next Q) $122.98M
Revenue Growth Est (next Q) 5.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $79.50
Price Target Upside -18.7%
Cash Flow
Operating Cash Flow $-48.71M
Free Cash Flow $-75.8M
Adj. Free Cash Flow $-111.5M
FCF Per Share -$2.55
OCF Per Share -$1.64
OCF/S Ratio -10.7%
Income Statement
Revenue $454.43M
Gross Profit $309.9M
Operating Income $-57.31M
EBITDA $-83.53M
Net Income $-106.36M
EPS (Diluted) -$3.62
Revenue / Employee $349.56K
Profit / Employee $-81.81K
Employees 1,300
Add to Watchlist
Select watchlists to add or remove WGS